Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Luggen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Geriatric Nursing (New York, N.Y.)|June 19, 2001
Treatment of rheumatic diseases in the elderlyM Luggen
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|July 21, 1998
Seropositive, symmetric polyarthritis in a patient with poorly differentiated lung carcinoma: carcinomatous polyarthritis, hypertrophic osteoarthropathy, or rheumatoid arthritis?Y Farhey, M Luggen
Lupus|June 17, 2011
Cognitive dysfunction in SLE: development of a screening toolT Adhikari, A Piatti, M Luggen
The Journal of Rheumatology|December 1, 1995
The evolution of Raynaud's phenomenon: a longterm prospective studyM Luggen, L Belhorn, T Evans, et al.
Annals of the Rheumatic Diseases|October 9, 2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapyM C Genovese, M Schiff, M Luggen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Geriatric Nursing (New York, N.Y.)|June 19, 2001
Treatment of rheumatic diseases in the elderlyM Luggen
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|July 21, 1998
Seropositive, symmetric polyarthritis in a patient with poorly differentiated lung carcinoma: carcinomatous polyarthritis, hypertrophic osteoarthropathy, or rheumatoid arthritis?Y Farhey, M Luggen
Lupus|June 17, 2011
Cognitive dysfunction in SLE: development of a screening toolT Adhikari, A Piatti, M Luggen
The Journal of Rheumatology|December 1, 1995
The evolution of Raynaud's phenomenon: a longterm prospective studyM Luggen, L Belhorn, T Evans, et al.
Annals of the Rheumatic Diseases|October 9, 2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapyM C Genovese, M Schiff, M Luggen, et al.
Pageof 1